Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 10, 2012, Pages 5061-5069

  Spanogiannopoulos, Peter ^a   Thaker, Maulik ^a   Koteva, Kalinka ^a   Waglechner, Nicholas ^a   Wright, Gerard D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLTRANSFERASE; RIFABUTIN; RIFAMPICIN; RIFAMYCIN B; RIFAXIMIN; RNA 16S; RNA POLYMERASE BETA SUBUNIT;

ACTINOBACTERIA; AMYCOLATOPSIS ECHIGONENSIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG STRUCTURE; ENZYME GLYCOSYLATION; ENZYME INACTIVATION; GENETIC ANALYSIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; STEADY STATE; STREPTOMYCES CASTANEUS; STREPTOMYCES CHARTREUSIS; STREPTOMYCES FLAVOVARIABILIS; STREPTOMYCES OLIVOVERTICILLATUS; STREPTOMYCES PSEUDOGRISEOLUS; STREPTOMYCES SPEIBONAE; STREPTOMYCES UMBRINUS; STREPTOMYCES VIRIDOCHROMOGENES;

ACTINOBACTERIA; BACTERIAL PROTEINS; GENOME, BACTERIAL; GLYCOSYLTRANSFERASES; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PHYLOGENY; RIFAMPIN; STREPTOMYCES;

EID: 84866309704     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01166-12     Document Type: Article

References (53)

1. Alekshun M, Kashlev M, Schwartz I. 1997. Molecular cloning and characterization of Borrelia burgdorferi rpoB. Gene 186:227-235. (Pubitemid 27107690)
2. Andersen SJ, Quan S, Gowan B, Dabbs ER. 1997. Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic. Antimicrob. Agents Chemother. 41:218-221. (Pubitemid 26428162)
3. Aristoff PA, Garcia GA, Kirchhoff PD, Hollis Showalter HD. 2010. Rifamycins - obstacles and opportunities. Tuberculosis (Edinb.) 90:94-118.
4. Arlet G, et al. 2001. Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase. Antimicrob. Agents Chemother. 45:2971-2972. (Pubitemid 32906708)
5. Baysarowich J, et al. 2008. Rifamycin antibiotic resistance by ADP-ribosylation: structure and diversity of Arr. Proc. Natl. Acad. Sci. U. S. A. 105:4886-4891. (Pubitemid 351753841)
6. Bolam DN, et al. 2007. The crystal structure of two macrolide glycosyltransferases provides a blueprint for host cell antibiotic immunity. Proc. Natl. Acad. Sci. U. S. A. 104:5336-5341. (Pubitemid 47175681)
7. Campbell EA, et al. 2001. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104:901-912. (Pubitemid 32289282)
8. Chevreux B, Wetter T, Suhai S. 1999. Genome sequence assembly using trace signals and additional sequence information, p 45-56. Proceedings of the German Conference on Bioinformatics (GCB). Universität Trier, Hanover, Germany.
9. Combrink KD, et al. 2007. New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases. Bioorg. Med. Chem. Lett. 17:522-526. (Pubitemid 46073733)
10. Cremonini F, Lembo A. 2012. Rifaximin for the treatment of irritable bowel syndrome. Expert Opin. Pharmacother. 13:433-440.
11. D'Costa VM, et al. 2011. Antibiotic resistance is ancient. Nature 477:457-461.
12. D'Costa VM, McGrann KM, Hughes DW, Wright GD. 2006. Sampling the antibiotic resistome. Science 311:374-377. (Pubitemid 43132661)
13. Desomer J, Dhaese P, Montagu MV. 1990. Transformation of Rhodococcus fascians by high-voltage electroporation and development of R. fascians cloning vectors. Appl. Environ. Microbiol. 56:2818-2825. (Pubitemid 20273118)
14. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792-1797. (Pubitemid 38832724)
15. Fischbach MA, Walsh CT. 2009. Antibiotics for emerging pathogens. Science 325:1089-1093.
16. Floss HG, Yu TW. 2005. Rifamycin - mode of action, resistance, and biosynthesis. Chem. Rev. 105:621-632. (Pubitemid 40351636)
17. Forrest GN, Tamura K. 2010. Rifampin combination therapy for non-mycobacterial infections. Clin. Microbiol. Rev. 23:14-34.
18. Gaurivaud P, Laigret F, Bove JM. 1996. Insusceptibility of members of the class Mollicutes to rifampin: studies of the Spiroplasma citri RNA polymerase beta-subunit gene. Antimicrob. Agents Chemother. 40:858-862. (Pubitemid 26115216)
19. Gill SK, Garcia GA. 2011. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro. Tuberculosis (Edinb.) 91:361-369.
20. Heuer H, Krsek M, Baker P, Smalla K, Wellington EM. 1997. Analysis of actinomycete communities by specific amplification of genes encoding 16S rRNA and gel-electrophoretic separation in denaturing gradients. Appl. Environ. Microbiol. 63:3233-3241. (Pubitemid 27337820)
21. Hoshino Y, et al. 2010. Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance. J. Antibiot. (Tokyo) 63:23-28.
22. Huang DB, DuPont HL. 2005. Rifaximin - a novel antimicrobial for enteric infections. J. Infect. 50:97-106.
23. Ishikawa J, Chiba K, Kurita H, Satoh H. 2006. Contribution of rpoB2 RNA polymerase beta subunit gene to rifampin resistance in Nocardia species. Antimicrob. Agents Chemother. 50:1342-1346.
24. Jin DJ, Gross CA. 1988. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202:45-58.
25. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA. 2000. Practical streptomyces genetics. John Innes Foundation Press, Norwich, United Kingdom.
26. Kim H, et al. 2005. Mechanism of natural rifampin resistance of Streptomyces spp. Syst. Appl. Microbiol. 28:398-404. (Pubitemid 40799584)
27. Kim TK, Hewavitharana AK, Shaw PN, Fuerst JA. 2006. Discovery of a new source of rifamycin antibiotics in marine sponge actinobacteria by phylogenetic prediction. Appl. Environ. Microbiol. 72:2118-2125.
28. Lairson LL, Henrissat B, Davies GJ, Withers SG. 2008. Glycosyltransferases: structures, functions, and mechanisms. Annu. Rev. Biochem. 77:521-555.
29. Li J, et al. 2007. Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins. Bioorg. Med. Chem. Lett. 17:5510-5513. (Pubitemid 47391331)
30. Mitani Y, Meng X, Kamagata Y, Tamura T. 2005. Characterization of LtsA from Rhodococcus erythropolis, an enzyme with glutamine amidotransferase activity. J. Bacteriol. 187:2582-2591. (Pubitemid 40490363)
31. Morisaki N, et al. 2000. Structures of ADP-ribosylated rifampicin and its metabolite: intermediates of rifampicin-ribosylation by Mycobacterium smegmatis DSM43756. J. Antibiot. (Tokyo) 53:269-275. (Pubitemid 30199079)
32. Mulichak AM, Losey HC, Walsh CT, Garavito RM. 2001. Structure of the UDP-glucosyltransferase GtfB that modifies the heptapeptide aglycone in the biosynthesis of vancomycin group antibiotics. Structure 9:547-557.
33. Murphy CK, et al. 2006. In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 50:827-834. (Pubitemid 43327784)
34. Nakashima N, Tamura T. 2004. Isolation and characterization of a rolling-circle-type plasmid from Rhodococcus erythropolis and application of the plasmid to multiple-recombinant-protein expression. Appl. Environ. Microbiol. 70:5557-5568. (Pubitemid 39279634)
35. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29. (Pubitemid 29050434)
36. Ronquist F, et al. 2012. MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space. Syst. Biol. 61:539-542.
37. Rothstein DM, van Duzer J, Sternlicht A, Gilman SC. 2007. Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections. Arch. Pharm. (Weinheim) 340:517-529. (Pubitemid 350007049)
38. Sánchez-Hidalgo M, Nunez LE, Mendez C, Salas JA. 2010. Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis. Antimicrob. Agents Chemother. 54:1684-1692.
39. Sensi P, Margalith P, Timbal MT. 1959. Rifomycin, a new antibiotic; preliminary report. Farmaco Sci. 14:146-147.
40. Shakya T, et al. 2011. A small molecule discrimination map of the antibiotic resistance kinome. Chem. Biol. 18:1591-1601.
41. Shao Z, Dick WA, Behki RM. 1995. An improved Escherichia coli-Rhodococcus shuttle vector and plasmid transformation in Rhodococcus spp. using electroporation. Lett. Appl. Microbiol. 21:261-266.
42. Stamm LV, Bergen HL, Shangraw KA. 2001. Natural rifampin resistance in Treponema spp. correlates with presence of N531 in RpoB Rif cluster I. Antimicrob. Agents Chemother. 45:2973-2974. (Pubitemid 32906709)
43. Tanaka Y, et al. 1996. Different rifampicin inactivation mechanisms in Nocardia and related taxa. Microbiol. Immunol. 40:1-4. (Pubitemid 26031695)
44. Tribuddharat C, Fennewald M. 1999. Integron-mediated rifampin resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:960-962. (Pubitemid 29165768)
45. Tupin A, et al. 2010. Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns. Int. J. Antimicrob. Agents 35:519-523.
46. Van Scoy RE, Wilkowske CJ. 1999. Antimycobacterial therapy. Mayo. Clin. Proc. 74:1038-1048.
47. Vilches C, Hernandez C, Mendez C, Salas JA. 1992. Role of glycosylation and deglycosylation in biosynthesis of and resistance to oleandomycin in the producer organism, Streptomyces antibioticus. J. Bacteriol. 174:161-165.
48. Wehrli W. 1977. Ansamycins. Chemistry, biosynthesis and biological activity. Top. Curr. Chem. 72:21-49.
49. Wright GD. 2007. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 5:175-186. (Pubitemid 46291277)
50. Wright GD. 2005. Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv. Drug Deliv. Rev. 57:1451-1470. (Pubitemid 40984601)
51. Yazawa K, et al. 1993. Inactivation of rifampin by Nocardia brasiliensis. Antimicrob. Agents Chemother. 37:1313-1317. (Pubitemid 23166732)
52. Yazawa K, Mikami Y, Maeda A, Morisaki N, Iwasaki S. 1994. Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum. J. Antimicrob. Chemother. 33:1127-1135. (Pubitemid 24201956)
53. Zhao L, Beyer NJ, Borisova SA, Liu HW. 2003. Beta-glucosylation as a part of self-resistance mechanism in methymycin/pikromycin producing strain Streptomyces venezuelae. Biochemistry 42:14794-14804. (Pubitemid 37553507)